EdgeMarket › What Alphabet Inc. reported owning
What Alphabet Inc. reported owning
As filed on Form 13F for the quarter ending 2026-03-31, up to 45 days after that date. Long-only US-listed equity — shorts, bonds, cash and non-US listings are not on the form, so this is one leg of the book, not the book.
Reported value
4.0BPositions
26Quarter
2026-03-31Shown below
26largest by value
| holding | value | % of book | shares | price | 1y |
|---|---|---|---|---|---|
| CME CME GROUP INC. | 1.0B | 25.6% | 3.5M | 274.98 | +0.1% |
| PL Planet Labs PBC | 985.2M | 24.5% | 35.2M | 22.29 | +246.7% |
| ASTS AST SpaceMobile, Inc. | 741.1M | 18.5% | 8.9M | 68.65 | +52.3% |
| RVMD Revolution Medicines, Inc. | 320.2M | 8.0% | 3.3M | 209.46 | +479.3% |
| ARM ARM HOLDINGS PLC /UK | 296.6M | 7.4% | 2.0M | 243.32 | +85.5% |
| FRSH Freshworks Inc. | 130.1M | 3.2% | 16.2M | 12.98 | -1.0% |
| PATH UiPath, Inc. | 78.1M | 1.9% | 7.0M | 16.39 | +49.5% |
| TEM Tempus AI, Inc. | 70.1M | 1.7% | 1.6M | 72.69 | -0.8% |
| PAYP PayPay Corp | 66.7M | 1.7% | 3.1M | 15.41 | — |
| GTLB Gitlab Inc. | 59.0M | 1.5% | 2.7M | 41.67 | -4.6% |
| PRME Prime Medicine, Inc. | 57.6M | 1.4% | 16.6M | 3.39 | +4.6% |
| LIFE Ethos Technologies Inc. | 42.1M | 1.0% | 3.8M | 34.16 | +2239.7% |
| MAZE Maze Therapeutics, Inc. | 41.4M | 1.0% | 1.4M | 29.43 | +118.3% |
| BBOT BridgeBio Oncology Therapeutics, Inc. | 25.3M | 0.6% | 2.8M | 9.08 | -5.7% |
| RLAY Relay Therapeutics, Inc. | 15.6M | 0.4% | 1.6M | 19.44 | +471.8% |
| GLUE Monte Rosa Therapeutics, Inc. | 11.3M | 0.3% | 684.3K | 14.30 | +222.8% |
| VERA Vera Therapeutics, Inc. | 9.7M | 0.2% | 241.3K | 32.27 | +46.0% |
| SANA Sana Biotechnology, Inc. | 8.1M | 0.2% | 2.8M | 3.91 | +12.7% |
| BEAM Beam Therapeutics Inc. | 7.7M | 0.2% | 321.6K | 29.76 | +85.3% |
| LYEL Lyell Immunopharma, Inc. | 5.9M | 0.1% | 293.3K | 15.53 | +45.8% |
| OSCR Oscar Health, Inc. | 5.5M | 0.1% | 482.0K | 32.04 | +109.8% |
| FIG Figma, Inc. | 4.6M | 0.1% | 215.6K | 27.10 | -63.4% |
| SPRO Spero Therapeutics, Inc. | 2.1M | 0.1% | 890.0K | 1.22 | -33.3% |
| HYPR Hyperfine, Inc. | 970.6K | 0.0% | 898.7K | 0.90 | -29.5% |
| AUTL Autolus Therapeutics plc | 963.6K | 0.0% | 698.3K | 2.41 | +39.3% |
| TNYA Tenaya Therapeutics, Inc. | 631.8K | 0.0% | 915.7K | 0.70 | -43.8% |
A position that grew quarter on quarter may simply reflect a higher price: if the stock rose 40% and the manager did nothing, the reported value rose 40%. Reading that as accumulation is reading the price back to yourself. More on that →
The whole archive is one click away.
Screener, filings, insider flow, backtests and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →